These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25263302)

  • 1. What is the contribution of protease inhibitors to the high mortality of patients with cirrhosis receiving HCV treatment?
    Tovo CV; Mattos AA; Almeida PR
    Gastroenterology; 2014 Nov; 147(5):1185. PubMed ID: 25263302
    [No Abstract]   [Full Text] [Related]  

  • 2. Risky business-the real life of the unresolved HCV therapy.
    Ferreira AO; Marinho RT
    Gastroenterology; 2014 Nov; 147(5):1185-6. PubMed ID: 25263294
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
    Hézode C; Fontaine H; Dorival C; Zoulim F; Larrey D; Canva V; De Ledinghen V; Poynard T; Samuel D; Bourliere M; Alric L; Raabe JJ; Zarski JP; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Chazouilleres O; Abergel A; Guyader D; Metivier S; Tran A; Di Martino V; Causse X; Dao T; Lucidarme D; Portal I; Cacoub P; Gournay J; Grando-Lemaire V; Hillon P; Attali P; Fontanges T; Rosa I; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP;
    Gastroenterology; 2014 Jul; 147(1):132-142.e4. PubMed ID: 24704719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
    Bublak R
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
    [No Abstract]   [Full Text] [Related]  

  • 5. The future for the treatment of genotype 4 chronic hepatitis C.
    Esmat G; El Raziky M; El Kassas M; Hassany M; Gamil ME
    Liver Int; 2012 Feb; 32 Suppl 1():146-50. PubMed ID: 22212586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple therapy with boceprevir or telaprevir for prior HCV non-responders.
    Asselah T
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):455-62. PubMed ID: 23199504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy].
    Deneke MG; Dranoff JA; Duarte-Rojo A
    Rev Gastroenterol Mex; 2014; 79(1):64-6. PubMed ID: 24679642
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic hepatitis viral C: new associations].
    Ouzan D
    Presse Med; 2013 Jun; 42(6 Pt 1):977-82. PubMed ID: 23021659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.
    Miailhes P; Gilbert C; Lacombe K; Arends JE; Puoti M; Rockstroh JK; Sogni P; Fontaine H; Rosenthal E; Winnock M; Loko MA; Wittkop L; Dabis F; Salmon D;
    Liver Int; 2015 Sep; 35(9):2090-9. PubMed ID: 25650873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
    Orlent H; Deltenre P; Francque S; Laleman W; Moreno C; Bourgeois S; Colle I; Delwaide J; De Maeght S; Mulkay JP; Stärkel P; Reynaert H;
    Acta Gastroenterol Belg; 2012 Jun; 75(2):245-59. PubMed ID: 22870791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hepatitis C infection. A revolution should not hide another].
    Sogni P
    Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837
    [No Abstract]   [Full Text] [Related]  

  • 13. [Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice].
    Albillos A; Luis Calleja J; Molina E; Planas R; Romero-Gómez M; Turnes J; Hernández-Guerra M
    Gastroenterol Hepatol; 2014 Jul; 37 Suppl 1():13-22. PubMed ID: 25907434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boceprevir for chronic HCV genotype 1 infection.
    Limaye AR; Draganov PV; Cabrera R
    N Engl J Med; 2011 Jul; 365(2):176; author reply 177-8. PubMed ID: 21751914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis C in HIV coinfection].
    Boesecke C; Rockstroh JK
    MMW Fortschr Med; 2012 May; 154 Suppl 1():42-4. PubMed ID: 22916601
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of HCV in cirrhosis-a rapidly evolving landscape.
    Sharma SA; Feld JJ
    Curr Gastroenterol Rep; 2015 May; 17(5):443. PubMed ID: 25896437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.
    Swiss Association for the Study of the Liver
    Swiss Med Wkly; 2012; 142():w13516. PubMed ID: 22367957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF).
    ; Coco B; Caraceni P; Aghemo A; Bitetto D; Bruno R; Ciancio A; Marzioni M; Petta S; Rendina M; Valenti L;
    Dig Liver Dis; 2014 Jan; 46(1):18-24. PubMed ID: 24119482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies for hepatitis C reach the clinic.
    Erdmann J
    Chem Biol; 2012 Apr; 19(4):433-4. PubMed ID: 22520745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.